<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Draft Guidance for Industry on Abbreviated New Drug Application Submissions-Refuse To Receive for Lack of Proper Justification of Impurity Limits; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Draft Guidance for Industry on Abbreviated New Drug Application Submissions-Refuse To Receive for Lack of Proper Justification of Impurity Limits; Availability</h1>
    <p class="timestamp">Published: 2014-09-17 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "ANDA Submissions--Refuse to Receive for Lack of Proper Justification of Impurity Limits." This draft guidance is intended to assist applicants preparing to submit to FDA abbreviated new drug applications (ANDAs) and related submissions (i.e., prior approval supplements) for which the applicant is seeking approval of a new strength of the drug product. The draft guidance highlights def...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2014-22110</p>
    <p><strong>Publication Date:</strong> 2014-09-17</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2014/09/17/2014-22110/draft-guidance-for-industry-on-abbreviated-new-drug-application-submissions-refuse-to-receive-for">https://www.federalregister.gov/documents/2014/09/17/2014-22110/draft-guidance-for-industry-on-abbreviated-new-drug-application-submissions-refuse-to-receive-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2014-22110</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
